This trade activity should not be overlooked: Biolife Solutions Inc (BLFS)

With 0.66 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.49 million shares. The 52-week range on BLFS shows that it touched its highest point at $29.55 and its lowest point at $17.15 during that stretch. It currently has a 1-year price target of $31.22. Beta for the stock currently stands at 1.90.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BLFS was down-trending over the past week, with a drop of -9.11%, but this was up by 8.33% over a month. Three-month performance dropped to -14.62% while six-month performance fell -12.52%. The stock gained 23.20% in the past year, while it has lost -13.87% so far this year. A look at the trailing 12-month EPS for BLFS yields -0.26 with Next year EPS estimates of 0.12. For the next quarter, that number is -0.04. This implies an EPS growth rate of 56.50% for this year and 214.02% for next year.

Float and Shares Shorts:

At present, 46.91 million BLFS shares are outstanding with a float of 45.58 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BLFS since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.43517 being high and -$0.49733 being low. For BLFS, this leads to a yearly average estimate of -$0.46625.